Rosetta Genomics Ltd.
ROSG
ROSG was delisted on the 21st of May, 2018.
11 hedge funds and large institutions have $1M invested in Rosetta Genomics Ltd. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
29% less capital invested
Capital invested by funds: $1.4M → $1M (-$399K)
79% less call options, than puts
Call options by funds: $7K | Put options by funds: $33K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
+$105K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$70K |
| 3 |
GF
Gerstein Fisher
New York
|
+$31.3K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$3.14K |
| 5 |
Citigroup
New York
|
+$1.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$72.9K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$71K |
| 3 |
Millennium Management
New York
|
-$43K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$39K |
| 5 |
ICAS
Investors Capital Advisory Services
Lynnfield,
Massachusetts
|
-$16.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highlander Capital Management
Short Hills,
New Jersey
| $605K | +$105K | +3,067 | +18% |
|
2
California Public Employees Retirement System
Sacramento,
California
| $125K | – | – | – |
|
|
3
Morgan Stanley
New York
| $76K | -$72.9K | -2,138 | -45% |
|
|
4
Citadel Advisors
Miami,
Florida
| $61K | +$70K | +2,054 | New |
|
|
ICAS
5
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| $37K | -$16.3K | -479 | -28% |
|
|
RCM
6
Rotella Capital Management
Bellevue,
Washington
| $37K | -$14.4K | -422 | -25% |
|
|
GF
7
Gerstein Fisher
New York
| $27K | +$31.3K | +917 | New |
|
|
8
Group One Trading
Chicago,
Illinois
| $26K | +$3.14K | +92 | +12% |
|
|
9
Citigroup
New York
| $3K | +$1.09K | +32 | +39% |
|
10
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $1K | +$1.02K | +30 | New |
|
|
VKH
12
Virtu KCG Holdings
New York
| – | -$71K | -1,750 | Closed |
|
|
13
Millennium Management
New York
| – | -$43K | -1,058 | Closed |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$39K | -965 | Closed |
|
ROSG Hedge Fund Activity: Q3 2015 in Review
11 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q3 2015, worth a combined $1M — down 29% from $1.4M a quarter earlier.
Fund positioning in ROSG was balanced in Q3 2015: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Highlander Capital Management, adding an estimated $105K. The largest seller was Morgan Stanley, cutting an estimated $72.9K.
- 11 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $1M of Rosetta Genomics Ltd. stock for Q3 2015, down 29% quarter-over-quarter.
- 3 funds opened new Rosetta Genomics Ltd. positions in Q3 2015 and 3 closed out, a net change of 0 holders.
- The largest Rosetta Genomics Ltd. buyer in Q3 2015 was Highlander Capital Management, an estimated $105K added.
- The largest Rosetta Genomics Ltd. seller in Q3 2015 was Morgan Stanley, an estimated $72.9K sold.
Based on aggregated 13F filings for Q3 2015.